Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies
2018/07/05 by Priyanka Garg, Vivek Garg, Rajani Shrestha +3 · 25 citations
Medicine · Neuroscience · Biochemistry, Genetics and Molecular Biology · #Cardiac electrophysiology and arrhythmias #Neuroscience and Neural Engineering #Ion channel regulation and function
paper · pdf · doi:10.1161/circresaha.118.311209
Abstract
Life threatening ventricular arrhythmias leading to sudden cardiac death are a major cause of morbidity and mortality. In the absence of structural heart disease, these arrhythmias, especially in the younger population, are often an outcome of genetic defects in specialized membrane proteins called ion channels. In the heart, exceptionally well-orchestrated activity of a diversity of ion channels mediates the cardiac action potential. Alterations in either the function or expression of these channels can disrupt the configuration of the action potential, leading to abnormal electrical activity of the heart that can sometimes initiate an arrhythmia. Understanding the pathophysiology of inherited arrhythmias can be challenging because of the complexity of the disorder and lack of appropriate cellular and in vivo models. Recent advances in human induced pluripotent stem cell technology have provided remarkable progress in comprehending the underlying mechanisms of ion channel disorders or channelopathies by modeling these complex arrhythmia syndromes in vitro in a dish. To fully realize the potential of induced pluripotent stem cells in elucidating the mechanistic basis and complex pathophysiology of channelopathies, it is crucial to have a basic knowledge of cardiac myocyte electrophysiology. In this review, we will discuss the role of the various ion channels in cardiac electrophysiology and the molecular and cellular mechanisms of arrhythmias, highlighting the promise of human induced pluripotent stem cell-cardiomyocytes as a model for investigating inherited arrhythmia syndromes and testing antiarrhythmic strategies. Overall, this review aims to provide a basic understanding of the electrical activity of the heart and related channelopathies, especially to clinicians or research scientists in the cardiovascular field with limited electrophysiology background.
Citations
Cited by
- Linking Arrhythmias and Adipocytes: Insights, Mechanisms, and Future Directions. [europepmc]
- Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms. [europepmc]
- The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019. [europepmc]
- Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture. [europepmc]
- Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. [europepmc]
- Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association. [europepmc]
- Inherited cardiac diseases, pluripotent stem cells, and genome editing combined-the past, present, and future. [europepmc]
- The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases. [europepmc]
- Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems. [europepmc]
- CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice. [europepmc]
- Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation. [europepmc]
- Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone. [europepmc]
- Innervation: the missing link for biofabricated tissues and organs. [europepmc]
- The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells. [europepmc]
- Clinical Trial in a Dish: Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity. [europepmc]
- iPSC-Cardiomyocyte Models of Brugada Syndrome-Achievements, Challenges and Future Perspectives. [europepmc]
- Maturing heart muscle cells: Mechanisms and transcriptomic insights. [europepmc]
- Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation. [europepmc]
- Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia. [europepmc]
- Progress in multicellular human cardiac organoids for clinical applications. [europepmc]
- Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes. [europepmc]
- Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals. [europepmc]
- Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes. [europepmc]
- iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development. [europepmc]
- Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions. [europepmc]
Related